Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 437 | 595 | 161 | 516 | 1,071 |
| Receivables | 58 | 59 | 54 | 25 | N/A |
| Other current assets | 0 | 0 | 22 | 55 | 23 |
| TOTAL | $521 | $663 | $238 | $660 | $1,094 |
| Non-Current Assets | |||||
| PPE Net | 2,000 | 4,315 | 8,466 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 388 | 0 |
| TOTAL | $2,000 | $4,315 | $8,466 | $388 | $0 |
| Total Assets | $2,521 | $4,978 | $8,704 | $1,047 | $1,094 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 131 | N/A | 38 |
| Accounts payable and accrued liabilities | 369 | 93 | 116 | N/A | 150 |
| TOTAL | $399 | $234 | $484 | $205 | $266 |
| Non-Current Liabilities | |||||
| Long Term Debt | 195 | 195 | 275 | N/A | N/A |
| TOTAL | $195 | $195 | $275 | $0 | $0 |
| Total Liabilities | $594 | $429 | $759 | $205 | $266 |
| Shareholders' Equity | |||||
| Common Shares | 16,501 | 15,701 | 14,046 | 5,765 | 5,515 |
| Retained earnings | -15,482 | -11,685 | -6,347 | -4,977 | -4,686 |
| Other shareholders' equity | 908 | 533 | 246 | 0 | 0 |
| TOTAL | $1,927 | $4,549 | $7,945 | $787 | $828 |
| Total Liabilities And Equity | $2,521 | $4,978 | $8,704 | $992 | $1,094 |